Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma

The aim of the study was to evaluate the potential diagnostic and prognostic value of gene, Poly A-Binding Protein Interacting Protein 2B (PAIP2B) in pancreatic cancer. We used the gene expression data and clinical information of pancreatic adenocarcinoma patients from The Cancer Genome Atlas databa...

Full description

Bibliographic Details
Main Authors: Yaoxian Xiang, Li Wang, Yurong Cheng, Huanjuan An, Chan Zhang, Jing Wang, Yingying Tong, Dong Yan
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2023-12-01
Series:Global Medical Genetics
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1777789
_version_ 1797385539700129792
author Yaoxian Xiang
Li Wang
Yurong Cheng
Huanjuan An
Chan Zhang
Jing Wang
Yingying Tong
Dong Yan
author_facet Yaoxian Xiang
Li Wang
Yurong Cheng
Huanjuan An
Chan Zhang
Jing Wang
Yingying Tong
Dong Yan
author_sort Yaoxian Xiang
collection DOAJ
description The aim of the study was to evaluate the potential diagnostic and prognostic value of gene, Poly A-Binding Protein Interacting Protein 2B (PAIP2B) in pancreatic cancer. We used the gene expression data and clinical information of pancreatic adenocarcinoma patients from The Cancer Genome Atlas database and Gene Expression Omnibus database to analyze the expression of PAIP2B in pancreatic cancer samples, and validated the expression of PAIP2B in tumor tissue, using bioinformatics technology to explore the prognostic value of PAIP2B and its possible biological function. A significantly lower level of PAIP2B was observed in pancreatic cancer patients than in controls, and validated by immunohistochemistry. PAIP2B reduced the proliferation and invasion of cancer cells and had a significantly high expression in early stage. Patients with lower levels of PAIP2B had a significantly shorter median survival time than those with higher levels. DNA demethylation played an important role in PAIP2B expression. In addition, PAIP2B expression was significantly associated with the tumor-infiltrating immune cells, especially T cells CD8, T cells CD4 memory resting, macrophages M0, and dendritic cells resting. Our study also found that PAIP2B regulated miRNA function leading to disease progression in pancreatic cancer patients. Our study explored the potential value of PAIP2B as a biological link between prognosis and pancreatic cancer, and provided reference for the follow-up study on the role of PAIP2B in pancreatic cancer.
first_indexed 2024-03-08T21:55:37Z
format Article
id doaj.art-01420ceafc0742079c5ab35501664495
institution Directory Open Access Journal
issn 2699-9404
language English
last_indexed 2024-03-08T21:55:37Z
publishDate 2023-12-01
publisher Georg Thieme Verlag KG
record_format Article
series Global Medical Genetics
spelling doaj.art-01420ceafc0742079c5ab355016644952023-12-19T23:52:59ZengGeorg Thieme Verlag KGGlobal Medical Genetics2699-94042023-12-01100438839410.1055/s-0043-1777789Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal AdenocarcinomaYaoxian Xiang0Li Wang1Yurong Cheng2Huanjuan An3Chan Zhang4Jing Wang5Yingying Tong6Dong Yan7Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaDepartment of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaDepartment of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaDepartment of Hematology, Peking University Shougang Hospital, Beijing, ChinaDepartment of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaDepartment of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaDepartment of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaDepartment of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, ChinaThe aim of the study was to evaluate the potential diagnostic and prognostic value of gene, Poly A-Binding Protein Interacting Protein 2B (PAIP2B) in pancreatic cancer. We used the gene expression data and clinical information of pancreatic adenocarcinoma patients from The Cancer Genome Atlas database and Gene Expression Omnibus database to analyze the expression of PAIP2B in pancreatic cancer samples, and validated the expression of PAIP2B in tumor tissue, using bioinformatics technology to explore the prognostic value of PAIP2B and its possible biological function. A significantly lower level of PAIP2B was observed in pancreatic cancer patients than in controls, and validated by immunohistochemistry. PAIP2B reduced the proliferation and invasion of cancer cells and had a significantly high expression in early stage. Patients with lower levels of PAIP2B had a significantly shorter median survival time than those with higher levels. DNA demethylation played an important role in PAIP2B expression. In addition, PAIP2B expression was significantly associated with the tumor-infiltrating immune cells, especially T cells CD8, T cells CD4 memory resting, macrophages M0, and dendritic cells resting. Our study also found that PAIP2B regulated miRNA function leading to disease progression in pancreatic cancer patients. Our study explored the potential value of PAIP2B as a biological link between prognosis and pancreatic cancer, and provided reference for the follow-up study on the role of PAIP2B in pancreatic cancer.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1777789pancreatic carcinoma PAIP2B overall survivalprognosisbiomarker
spellingShingle Yaoxian Xiang
Li Wang
Yurong Cheng
Huanjuan An
Chan Zhang
Jing Wang
Yingying Tong
Dong Yan
Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma
Global Medical Genetics
pancreatic carcinoma
PAIP2B
overall survival
prognosis
biomarker
title Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma
title_full Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma
title_fullStr Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma
title_short Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma
title_sort integrative analysis of i paip2b i to identify a novel biomarker for pancreatic ductal adenocarcinoma
topic pancreatic carcinoma
PAIP2B
overall survival
prognosis
biomarker
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1777789
work_keys_str_mv AT yaoxianxiang integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT liwang integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT yurongcheng integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT huanjuanan integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT chanzhang integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT jingwang integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT yingyingtong integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma
AT dongyan integrativeanalysisofipaip2bitoidentifyanovelbiomarkerforpancreaticductaladenocarcinoma